Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Meningococcal vaccine groups A C Y W-135 conjugate - Sanofi

Next Previous
X
Search
Drug Profile

Meningococcal vaccine groups A C Y W-135 conjugate - Sanofi

Alternative Names: MCV-4; Menactra; Menactra Infant/Toddler; Menactra Toddler; MenACYW-TT; Meningo ACWY; Meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine; Meningococcal polysaccharide diphtheria toxoid conjugate vaccine; SP284

Latest Information Update: 06 Apr 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi pasteur
  • Developer Novartis Vaccines; Sanofi
  • Class Conjugate vaccines; Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Meningococcal infections

Most Recent Events

  • 05 Jul 2019 Launched for Meningococcal infections (In infants, In neonates, Prevention) in India prior July 2019 (IM)
  • 02 Jul 2018 SK Chemicals divested the vaccine business portfolio to a newly formed subsidiary SK Bioscience
  • 05 Dec 2016 Sanofi completes a phase II trial for Meningococcal infections (Prevention, In infants, In children, In adolescents, In adults) in Vietnam (NCT02640404)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top